IL132999A0 - Process for making flurbiprofen lozenges - Google Patents

Process for making flurbiprofen lozenges

Info

Publication number
IL132999A0
IL132999A0 IL13299998A IL13299998A IL132999A0 IL 132999 A0 IL132999 A0 IL 132999A0 IL 13299998 A IL13299998 A IL 13299998A IL 13299998 A IL13299998 A IL 13299998A IL 132999 A0 IL132999 A0 IL 132999A0
Authority
IL
Israel
Prior art keywords
making
lozenges
flurbiprofen lozenges
making flurbiprofen
flurbiprofen
Prior art date
Application number
IL13299998A
Other languages
English (en)
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of IL132999A0 publication Critical patent/IL132999A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13299998A 1997-05-22 1998-05-20 Process for making flurbiprofen lozenges IL132999A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710521.7A GB9710521D0 (en) 1997-05-22 1997-05-22 Process
PCT/EP1998/003167 WO1998052539A1 (en) 1997-05-22 1998-05-20 Process for making flurbiprofen lozenges

Publications (1)

Publication Number Publication Date
IL132999A0 true IL132999A0 (en) 2001-03-19

Family

ID=10812840

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13299998A IL132999A0 (en) 1997-05-22 1998-05-20 Process for making flurbiprofen lozenges

Country Status (31)

Country Link
US (1) US6194003B1 (es)
EP (1) EP0983059B1 (es)
JP (1) JP2001527567A (es)
KR (1) KR20010012739A (es)
CN (1) CN1154480C (es)
AR (1) AR015812A1 (es)
AT (1) ATE245021T1 (es)
AU (1) AU725760B2 (es)
BG (1) BG103881A (es)
BR (1) BR9809651A (es)
CA (1) CA2290830C (es)
CZ (1) CZ290816B6 (es)
DE (1) DE69816440T2 (es)
DK (1) DK0983059T3 (es)
ES (1) ES2202871T3 (es)
GB (1) GB9710521D0 (es)
HU (1) HU224954B1 (es)
ID (1) ID22949A (es)
IL (1) IL132999A0 (es)
IN (1) IN187837B (es)
MY (1) MY118410A (es)
NO (1) NO995681D0 (es)
NZ (1) NZ500664A (es)
PL (1) PL190947B1 (es)
PT (1) PT983059E (es)
RU (1) RU2203046C2 (es)
SK (1) SK283701B6 (es)
TR (1) TR199902725T2 (es)
UA (1) UA53714C2 (es)
WO (1) WO1998052539A1 (es)
ZA (1) ZA984260B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124124B2 (en) 1999-12-09 2012-02-28 Reckitt Benckiser Healthcare (Uk) Limited Compressed tablet formulation comprising non-steroidal anti-inflammatory drugs and methods
AU2001257022B2 (en) * 2000-04-13 2005-02-03 Mayo Foundation For Medical Education And Research Abeta 42 lowering agents
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
JP2007528857A (ja) * 2003-07-11 2007-10-18 ミリアド ジェネティクス， インコーポレイテッド アルツハイマー病の処置のための薬学的方法、投与レジメンおよび投薬形態
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
KR20070004036A (ko) * 2004-04-29 2007-01-05 키스톤 리테이닝 월 시스템스, 아이엔씨 벽, 옹벽 및 그 외 유사한 것을 위한 베니어
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
CN101128186B (zh) 2005-02-03 2013-07-03 奈科明制药有限公司 制备含钙组合物的快速湿聚结方法
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
EP1909777A2 (en) * 2005-07-22 2008-04-16 Myriad Genetics, Inc. High drug load formulations and dosage forms
AU2006312119B2 (en) * 2005-11-02 2010-04-29 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
WO2008006099A2 (en) * 2006-07-07 2008-01-10 Myriad Genetics, Inc. Treatment of psychiatric disorders
EA200901188A1 (ru) * 2007-07-23 2010-04-30 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Органолептически приемлемые дозированные лекарственные формы индольных агонистов серотониновых рецепторов для перорального применения и способы их применения
WO2010020772A2 (en) * 2008-08-22 2010-02-25 Reckitt Benckiser Healthcare (Uk) Limited Improvements in or relating to compositions
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
PL3284459T3 (pl) 2011-04-29 2021-06-28 Moberg Pharma Ab Kompozycje farmaceutyczne zawierające środek miejscowo znieczulający, taki jak bupiwakaina, do podawania miejscowego do jamy ustnej lub gardła
EP2609911A1 (en) * 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. A novel process for preparing orally disintegrating flurbiprofen formulations
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
JP6315741B2 (ja) * 2015-08-18 2018-04-25 合同会社Ｐｈａｒｍａ Ｓｅｅｄｓ Ｃｒｅａｔｅ ＮＳＡＩＤｓまたはヘパリン類含有口腔用組成物
WO2020013781A2 (en) * 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
IT1243342B (it) 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
RU2203046C2 (ru) 2003-04-27
PL336624A1 (en) 2000-07-03
WO1998052539A1 (en) 1998-11-26
JP2001527567A (ja) 2001-12-25
DK0983059T3 (da) 2003-11-03
BR9809651A (pt) 2000-07-11
TR199902725T2 (xx) 2000-02-21
BG103881A (en) 2000-05-31
CN1154480C (zh) 2004-06-23
ES2202871T3 (es) 2004-04-01
PL190947B1 (pl) 2006-02-28
NO995681L (no) 1999-11-19
EP0983059A1 (en) 2000-03-08
AR015812A1 (es) 2001-05-30
HUP0002121A2 (hu) 2000-12-28
KR20010012739A (ko) 2001-02-26
CN1255848A (zh) 2000-06-07
CZ412099A3 (cs) 2000-02-16
UA53714C2 (uk) 2003-02-17
CA2290830C (en) 2006-07-11
HU224954B1 (en) 2006-04-28
IN187837B (es) 2002-06-29
GB9710521D0 (en) 1997-07-16
HUP0002121A3 (en) 2001-04-28
ZA984260B (en) 1999-02-20
DE69816440D1 (de) 2003-08-21
EP0983059B1 (en) 2003-07-16
SK283701B6 (sk) 2003-12-02
SK158899A3 (en) 2000-05-16
NZ500664A (en) 2001-01-26
DE69816440T2 (de) 2004-05-13
NO995681D0 (no) 1999-11-19
ID22949A (id) 1999-12-16
AU7916598A (en) 1998-12-11
CA2290830A1 (en) 1998-11-26
PT983059E (pt) 2003-11-28
CZ290816B6 (cs) 2002-10-16
ATE245021T1 (de) 2003-08-15
MY118410A (en) 2004-10-30
AU725760B2 (en) 2000-10-19
US6194003B1 (en) 2001-02-27

Similar Documents

Publication Publication Date Title
IL132999A0 (en) Process for making flurbiprofen lozenges
GB9723295D0 (en) Novel process
GB9719426D0 (en) Novel process
EP0986389A4 (en) NEW PROCESS
HUP9904325A3 (en) Process for johexol manufacture
IL122454A (en) Process for forming bubble-pack
GB9700690D0 (en) Novel process
GB9626570D0 (en) Process for making benzisothiazolin-3-ones
ZA983174B (en) Novel process
EP0990658A4 (en) PROCESS FOR PRODUCING TRIHYDROCARBYLALUMINUMS
MD810F1 (en) Process for modified ionites obtaining
HUP9903692A3 (en) Process for making dihydropyrimidinones
GB9505179D0 (en) Process for fluoroaromatics
GB9716566D0 (en) Novel process
GB9713097D0 (en) Novel process
GB9719174D0 (en) Novel process
GB9718700D0 (en) Novel process
GB9722694D0 (en) Novel process
GB9714875D0 (en) Novel process
GB9714872D0 (en) Novel process
GB9714049D0 (en) Novel process
GB9714045D0 (en) Novel process
GB9714042D0 (en) Novel process
GB9714012D0 (en) Novel process
GB9713554D0 (en) Novel process

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees